Natco Pharma - Next Leg
A fundamentally sound company with a super management.
The stock could be due its next leg. It had a recent breakout retest and successfuly bounced.
Long above 900% SL 3-5% below purchase price. Its not a trading buy but more for an investment kind of play.
The stock could be due its next leg. It had a recent breakout retest and successfuly bounced.
Long above 900% SL 3-5% below purchase price. Its not a trading buy but more for an investment kind of play.
免責事項
これらの情報および投稿は、TradingViewが提供または保証する金融、投資、取引、またはその他の種類のアドバイスや推奨を意図したものではなく、またそのようなものでもありません。詳しくは利用規約をご覧ください。